Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NextCure, Inc.

NASDAQ: NXTC · Life Sciences · 7 alerts · CIK 1661059

Share price
$6.68Close, Nov 16
Market cap
$30.6M
Shares outstanding
4.58MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NextCure, Inc. filings on SEC EDGAR ↗

8:00 AM ET 8-K
Leadership Change

NextCure Leadership Change

NextCure, Inc. announced that Chief Medical Officer Dr. Udayan Guha will be terminated effective October 31, 2026. The departure is in contemplation of the company's pending merger with Avere Therapeutics, Inc. Dr. Guha will receive severance benefits consistent with a termination without cause, including enhanced benefits if the merger closes.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.